Sarthi Lifesciences

NPPA Revises Ceiling Prices of 923 Scheduled Drug Formulations

The Department of Pharmaceuticals has issued its annual list of revised ceiling prices for 923 scheduled drug formulations and revised retail prices for 65 formulations. These changes are scheduled to come into effect from April 1st. Price Revision Basis The revision in ceiling and retail prices is based on a 0.00551% increase in the wholesale […]